Global Partners Executive to Sell $1.95M in Stock on NYSE

Global Partners LP insider Mark Romaine has filed Form 144 indicating a proposed sale of 36,000 common shares with an aggregate market value of $1,953,212.40.

Accepted by SEC EDGAR 06/25/2025 - 03:46 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Global Partners LP insider Mark Romaine has filed Form 144 indicating a proposed sale of 36,000 common shares with an aggregate market value of $1,953,212.40. The shares are to be sold through Raymond James & Associates on the NYSE, with an approximate sale date of June 24, 2025.

The securities to be sold were acquired through multiple phantom grant transactions in 2025:

• 12,686 shares on March 4, 2025
• 5,765 shares on March 27, 2025
• 11,479 shares on May 6, 2025
• 6,070 shares on January 17, 2025

The filing also discloses that Romaine previously sold 12,800 shares on March 25, 2025, for gross proceeds of $677,305. The total shares outstanding are 33,995,563. All shares were acquired as compensation through phantom grants from the issuer.

Positive

• None.

Negative

• Executive Mark Romaine plans to sell 36,000 shares worth approximately $1.95M, following a recent sale of 12,800 shares in March 2025 worth $677K, indicating continued insider selling pressure

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GLP shares are being sold according to the Form 144 filing from June 2023?

According to the Form 144 filing, 36,000 shares of GLP common stock are being proposed for sale through Raymond James & Associates, with an aggregate market value of $1,953,212.40.

When did Mark Romaine last sell GLP shares before this Form 144 filing?

Mark Romaine's last reported sale was on March 25, 2025, when he sold 12,800 shares of GLP common stock for gross proceeds of $677,305.00.

How did the insider acquire the GLP shares being sold?

The shares were acquired through multiple Phantom Grant transactions as compensation on different dates: 12,686 shares on 03/04/2025, 5,765 shares on 03/27/2025, 11,479 shares on 05/06/2025, and 6,070 shares on 01/17/2025.

What is the current total number of outstanding shares of GLP?

According to the Form 144 filing, Global Partners LP (GLP) has 33,995,563 shares outstanding.

What is the planned sale date for the GLP shares in this Form 144?

The approximate date of sale indicated in the Form 144 filing is June 24, 2025, and the shares will be sold on the NYSE (New York Stock Exchange).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001578638
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GLOBAL PARTNERS LP
SEC File Number	001-32593
Address of Issuer	P.O. BOX 9161 800 SOUTH STREET, SUITE 500 WALTHAM MASSACHUSETTS 02454
Phone	(781) 894-8800
Name of Person for Whose Account the Securities are To Be Sold	Romaine Mark
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	36000	1953212.40	33995563	06/24/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/04/2025	PHANTON GRANT	Issuer			12686	03/04/2025	Compensation
Common	03/27/2025	PHANTON GRANT	Issuer			5765	03/27/2025	Compensation
Common	05/06/2025	PHANTON GRANT	Issuer			11479	05/06/2025	Compensation
Common	01/17/2025	PHANTON GRANT	Issuer			6070	01/17/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mark Romaine 800 South Street Waltham MA 02454	Common	03/25/2025	12800	677305.00

144: Remarks and Signature

Remarks
Date of Notice	06/25/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/25/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Maressia Rooks-Bailey, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Mark Romaine
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)